Stay updated on PF-06463922 ALK/ROS1 Inhibitor Clinical Trial
Sign up to get notified when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.

Latest updates to the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.6.5 replaces the previous v3.6.4, updating the page's displayed site revision. This signals a new build/version of the ClinicalTrials.gov interface without altering the underlying study records.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page history now shows the latest revision as v3.6.4, replacing the previous v3.6.3, indicating the record has been updated to a newer version. No study data or public content changes are reflected in this entry.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page footer now shows Revision: v3.6.3, indicating a newer build was deployed; the previous Revision: v3.6.2 is no longer displayed.SummaryDifference0.0%

- Check61 days agoChange DetectedA new revision entry (v3.6.2) is now shown in the page history, replacing the prior v3.6.0 entry. The update reflects a version bump of the page itself rather than substantive changes to the study information.SummaryDifference0.0%

- Check75 days agoChange DetectedA new history entry for version 3.6.0 is added and a 'No longer looking for participants' note appears, while the 'Revision: v3.5.5' text is removed from the history.SummaryDifference0.2%

- Check82 days agoChange DetectedThe page metadata was updated from v3.5.4 to v3.5.5, indicating a new release of the page. This update does not modify study data, results, or visible content.SummaryDifference0.0%

Stay in the know with updates to PF-06463922 ALK/ROS1 Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.